BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250519
DTEND;VALUE=DATE:20250521
DTSTAMP:20260515T094340
CREATED:20250402T111945Z
LAST-MODIFIED:20250402T111945Z
UID:40815-1747612800-1747785599@www.pharmajournalist.com
SUMMARY:TPD & Induced Proximity Pharma Partnering Summit
DESCRIPTION:From molecular glue discovery to the development of degrader-antibody conjugates\, pharma is transforming through strategic transactions and by leveraging protein degradation technologies to expand target discovery and drug previously ‘undruggable’ targets. \nThis provides biotech with the opportunity to understand pharma’s targets of interest and the options for increased specificity and selectivity compared to traditional molecules. \nJoin the TPD & Induced Proximity Pharma Partnering Summit to accelerate partnership interest in your protein degradation pipeline or platform\, by hearing first-hand: \n\nWhat: What are pharma’s targets of interest\, and what data is sparking or prohibiting deal-making across TPD?\nWho: Who is the right person at each pharma\, specifically for induced proximity assets?\nHow: How are pharma analyzing data for a research collaboration versus a licensing deal?\n\nVIEW THE FULL EVENT GUIDE \nSecure your place here or get in touch with the team – info@hansonwade.com
URL:http://www.pharmajournalist.com/event/tpd-induced-proximity-pharma-partnering-summit/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:General Enquiries: info@hansonwade.com or Partnership Enquiries: sponsor@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250520
DTEND;VALUE=DATE:20250523
DTSTAMP:20260515T094340
CREATED:20250225T113954Z
LAST-MODIFIED:20250225T113954Z
UID:40583-1747699200-1747958399@www.pharmajournalist.com
SUMMARY:4th GPCRs-Targeted Drug Discovery Summit
DESCRIPTION:The 4th GPCR-Targeted Drug Discovery Summit: Transforming the Discovery of Novel GPCR-Targeted Therapies. \nWith positive clinical read outs by Tectonic Therapeutics and recent funding rounds for Confo Therapeutics & Septerna\, the potential for novel GPCR drug classes to treat a plethora of diseases grows. Now more than ever\, there is a need for the community to come together to share scientific advancements and collaboration opportunities across the full spectrum of GPCR drugs\, from small molecules to therapeutic proteins and antibodies. \nThe 4th GPCRs-Targeted Drug Discovery Summit is returning to Boston to showcase the hottest targets of interest\, mechanism of action of new GPCR ligands\, cutting-edge computational tools to identify high-potential candidates\, and effective translational strategies to drive forward discovery & development pipelines to patients in need.\n\nFind out everything you need to know about the Summit here: https://ter.li/2c54a7
URL:http://www.pharmajournalist.com/event/4th-gpcrs-targeted-drug-discovery-summit/
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250520
DTEND;VALUE=DATE:20250523
DTSTAMP:20260515T094340
CREATED:20250422T121846Z
LAST-MODIFIED:20250422T122446Z
UID:40956-1747699200-1747958399@www.pharmajournalist.com
SUMMARY:6th Gene Therapy Analytical Development Summit Europe
DESCRIPTION:The 6th Gene Therapy Analytical Development Summit Europe is the leading platform for advancing gene therapy analytics\, from IND/IMPD filings to clinical trials and regulatory approvals. As the field moves toward late-stage development\, gain industry-focused insights tailored for Europe. \nJoin 24+ experts to tackle characterisation\, stability\, contamination risks\, and comparability across vectors and diseases. Network with biotech\, pharma\, MHRA\, and British Pharmacopoeia to share solutions and shape the future of gene therapy. \nDon’t miss the chance to explore analytical precision\, QC strategy\, and the delivery of safe\, effective therapies! \nTo know more visit: https://ter.li/w8deua
URL:http://www.pharmajournalist.com/event/6th-gene-therapy-analytical-development-summit-europe/
LOCATION:Novotel London West\, 1 Shortlands\, Hammersmith\, London\, W6 8DR\, United Kingdom
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR